Communiqués Integrum AB

Actions

INTEG B

SE0009807266

Equipement, fournitures et distribution médicale

Marché Fermé - Nasdaq Stockholm 18:00:00 17/09/2026			Varia. 5j.	Varia. 1 janv.
9,320 ^SEK	+8,37%		+5,31%	-13,38%

20:51	Integrum AB annonce l'implantation du premier système e-OPRA aux États-Unis dans le cadre d'une étude clinique dirigée par le Shirley Ryan AbilityLab	CI
16:04	Integrum traite son premier patient dans le cadre de l'étude américaine e-OPRA	FW

Communiqués

16:01	First U.S. Patient Receives Integrum's e-OPRA in Clinical Study Led by Shirley Ryan AbilityLab	AQ
16/09	Integrum has completed a directed share issue of Class B shares, raising approximately SEK 22.9 million	AQ
12/09	Integrum publishes Annual Report 2025/26	AQ
08/09	Integrum welcomes the Ukrainian Cabinet of Ministers’ decision to introduce a state-funded pilot program for osseointegration	AQ
03/09	Integrum publishes interim report for the first quarter of 2026/27	AQ
31/08	Integrum invites to presentation of Q1 2026/27 results	AQ
03/08	Nomination Committee appointed in Integrum AB (publ) ahead of the 2026 Annual General Meeting	AQ
28/07	Integrum receives additional custom duty refund of approximately SEK 3.3 million	AQ
29/06	Ukraine's Ministry of Health submits proposal to the government on expanded use of osseointegration in healthcare	AQ
16/06	Integrum receives customs duty refund of approximately SEK 2.6 million	AQ
09/06	Integrum intends to incorporate all operations within bionics under the name Afyri	AQ
04/06	YEAR-END REPORT 2025/2026	AQ
01/06	Integrum invites to presentation of Q4 2025/26 results	AQ
05/05	Integrum launches patient-facing website in the US to increase patient flow and awareness of OPRA Implant System	AQ
30/04	Integrum implements a write-down of approximately SEK 7 million following reclassification of certain inventory items	AQ
15/04	Integrum accelerates Ukraine expansion following landmark decision to expand osseointegration treatment in national healthcare	AQ
05/03	Integrum : Interim Report Q3 2025/26	PU
05/03	Integrum publishes Interim Report for the third quarter 2025/26	AQ
03/03	Integrum invites to presentation of Q3 2025/26 results	AQ
20/02	Integrum: Discontinuing coverage	AQ
11/02	Integrum optimizes organization to further accelerate commercialization of OPRA Implant System	AQ
02/12	Integrum's rights issue oversubscribed	AQ
21/11	Integrum publishes Interim Report for Q2 2025/26	AQ
19/11	Integrum AB: Invitation to the Second Quarter 2025/26 Results Presentation	AQ
18/11	The subscription period in Integrum's rights issue has begun	AQ